Co-Authors
This is a "connection" page, showing publications co-authored by Iwan van der Horst and Alexander Vlaar.
Connection Strength
0.277
-
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial. Lancet Rheumatol. 2020 Dec; 2(12):e764-e773.
Score: 0.226
-
Coronary Angiography after Cardiac Arrest without ST-Segment Elevation. N Engl J Med. 2019 Apr 11; 380(15):1397-1407.
Score: 0.051